Age-Dependent Decrease of DNA Hydroxymethylation in Human T Cells

Area of Science:

• Epigenetics
• Molecular Biology
• Aging Research

Background:

• Hydroxymethylcytosine (hmC) is a key epigenetic mark derived from methylcytosine (mC) by TET dioxygenases.
• Reduced hmC and TET2 mutations are linked to myeloid and T-cell cancers.
• The role of hmC in the aging process is not well understood.

Purpose of the Study:

• To investigate the relationship between hydroxymethylcytosine (hmC) levels and aging in human peripheral blood T cells.
• To examine the age-dependent expression patterns of TET methylcytosine dioxygenase family enzymes (TET1-3).
• To explore the correlation between genomic hmC content and TET enzyme expression in aging T cells.

Main Methods:

• Quantification of genomic hmC content in peripheral blood T cells from 53 human volunteers.
• Measurement of mRNA expression levels for TET1, TET2, and TET3.
• Statistical analysis to determine correlations between age, hmC levels, and TET gene expression.

Main Results:

• Genomic hmC content significantly decreased with increasing age in T cells.
• mRNA expression of TET1 and TET3 showed a decline with age, while TET2 expression remained stable.
• Genomic hmC levels were positively correlated with TET3 mRNA expression but not with TET1 or TET2.

Conclusions:

• Aging is associated with decreased hmC levels in human T cells.
• TET3 expression, but not TET1 or TET2, is a key regulator of hmC levels during T-cell aging.
• These findings suggest novel epigenetic regulatory mechanisms contributing to T-cell aging.